Twitter Beğeni Hilesi

Un torneo fantástico e inolvidable. A mis compañeros dedico estos premios, sin ellos no hubiera sido posible. Lo intentaremos las veces que sea necesario, volveremos! 🇨🇴

Today we celebrated Dr. Carolyn Y. Ho’s promotion to Professor Of Medicine at HMS, as well as several other promotions and accomplishments within the Women in Cardiovascular Medicine Faculty. Congratulations to all! cvls.bwh.harvard.edu/women-in-cardi…

De Cúcuta para el mundo ❤️🖤🇨🇴

It is official: the Venezuelan electoral authority fraudulently announced Maduro’s victory. This is a sham. Proving fraud will be a cakewalk if and when the results are published. This crime cannot be allowed to stand.

El régimen de Maduro debe entender que los resultados que publica son difíciles de creer. La comunidad internacional y sobre todo el pueblo venezolano, incluyendo a los millones de venezolanos en el exilio, exigimos total transparencia de las actas y el proceso, y que veedores

Congrats Juan Cubillos-Ruiz and Suzanne Cloonan Lab !

Insights from #PARADISE-MI Following #AMI, Sa/Val led to more initial serum Cr increases than #ramipril, but not linked to adverse CV outcomes or long-term kidney issues onlinelibrary.wiley.com/doi/full/10.10… European Society of Cardiology Journals #EJHF scottdavidsolomon Amr Abdin Henry Han Giuseppe Galati

Yo entiendo las ganas de ver estrategia en el silencio de Petro, pero si algo no le ha importado a este presidente es la diplomacia y mucho menos la prudencia, ni siquiera en los momentos más álgidos cuando habría sido conveniente. ¿Un Petro silencioso? Sospechoso a morir.

Venezuela libre ya! 🇻🇪

Después de 6 días de brutal represión, creyeron que nos iban a callar, a parar o atemorizar… miren la respuesta. Hoy, la presencia de que cada ciudadano en las calles de Venezuela demuestra la magnitud de la fuerza cívica que tenemos y la determinación de llegar hasta el

*Breaking* P3 #FINEARTSHF meets its primary endpoint (CVd+total HF events)! Non-steroidal MRA finerenone "demonstrates definitive CV benefits" in HFmrEF & HFpEF Looking forward to presenting full results at #ESCCongress alongside scottdavidsolomon Pardeep S Jhund bayer.com/media/en-us/fi…

Our latest in Circulation: Genomic and Precision Medicine led by Maddalena Ardissino Buu Truong uses 🧬 approaches triangulating 2 proteomic platforms (Olink + SomaScan) 🧪 and GTEx to prioritize causal biomarkers in preeclampsia 🤰🚨 SERPINE2, PZP, FGF5, FES, ANP supported by all evidence 👇 ahajournals.org/doi/abs/10.116…

Now in JACC Journals #JACC , our paper led by John Ostrominski + So Mi Jemma Cho 👀 🫀/🫘 outcomes in midlife adults w/ T1D vs. T2D in the UK Biobank Despite ⬆️ CV risk factor control in T1D, T1D assoc'd w/ ⬆️ risk of cardiorenal events + death vs. T2D 👇 jacc.org/doi/10.1016/j.…

Join our August campaign #Corazondemama together with SIAC @MujerSIAC GoRedforWomen IAHFnews we want to improve the cardiovascular health of all women Icahn School of Medicine at Mount Sinai Mount Sinai Health System American College of Cardiology National Hispanic Medical Association #LatinasInMedicine

Beta-blocker use and outcomes in patients with #HeartFailure and mildly reduced and preserved ejection fraction released at #ESCCongress and just published in #EJHF👉 bit.ly/3Tbt2hr EJHF Editor-in-Chief Faiez ZANNAD

🔥 A new therapeutic era in #HFpEF #FINEARTSHF with definitive evidence supporting the role of the non-steroidal MRA finerenone at #ESCCongress Now in NEJM nejm.org/doi/full/10.10…

What a pleasure to see my mentors presenting the results of #FINEARTS at #ESC2024. Finerenone reduced the primary combined endpoint of HF hosp. and CV death in patients with HFmrEF and HFpEF

#ESCCongressVisuals for Hotline 7: FINEARTS-HF - #Finerenone in #HeartFailure with mildly reduced and preserved ejection fraction MRAs in #HF - An individual patient data meta-analysis of randomised trials FINE-HEART - Participant-level pooled analysis of finerenone in

What an incredible #ESCCongress - so much fantastic and practice changing science Our The George Institute for Global Health/Brigham and Women's Hospital Harvard Medical School publications on the intersection of heart failure & CKD featured in Nature Medicine, Circulation, JACC Journals, and The Lancet Public Health

September is #WomeninMedicineMonth! To celebrate, we want to recognize the 2024 Claflin Distinguished Scholars. Meet Emily Lau, MD, a 2024 Claflin Scholar from Mass General Heart. Read more about her work: mgriblog.org/2024/07/29/con…